SCHEMBL20657293

SCHEMBL20657293

O=C(C=Cc1ccccc1)Nc1ccccc1S(=O)(=O)Nc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 12/20 0.60
MMP1 P03956 5/20 0.59
MMP2 P08253 5/20 0.59
MMP9 P14780 5/20 0.59
EGFR P00533 5/20 0.59
MAOA P21397 1/20 0.59
MAOB P27338 1/20 0.59
HDAC3 O15379 4/20 0.58
HDAC4 P56524 4/20 0.58
HDAC7 Q8WUI4 4/20 0.58
HDAC2 Q92769 4/20 0.58
HDAC10 Q969S8 4/20 0.58
HDAC11 Q96DB2 4/20 0.58
HDAC8 Q9BY41 4/20 0.58
HDAC6 Q9UBN7 4/20 0.58
HDAC9 Q9UKV0 4/20 0.58
HDAC5 Q9UQL6 4/20 0.58
BRD4 O60885 1/20 0.56
ESR1 P03372 1/20 0.56
PTGS1 P23219 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20657290 0.88 NAMPT (0.59)
SCHEMBL20657342 0.85 ALDH1A1 (0.54) HDAC1MMP1MMP2MMP9EGFR
SCHEMBL20657324 0.84 EGFR (0.50) HDAC1EGFRMAOBHDAC3HDAC4
SCHEMBL20657312 0.84 HDAC1 (0.47) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL20657351 0.84 HDAC1 (0.50) HDAC1MMP1MMP2MMP9EGFR
SCHEMBL11063104 0.83 MMP1 (0.63) HDAC1MMP1MMP2MMP9EGFR
SCHEMBL11063103 0.83 MMP1 (0.63) HDAC1MMP1MMP2MMP9EGFR
SCHEMBL3820006 0.82 TGM2 (0.56) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL23881374 0.81 HDAC1 (0.50) HDAC1MMP1MMP2MMP9EGFR
SCHEMBL20657340 0.81 HDAC1 (0.45) HDAC1MAOBHDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278971-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES VERSITECH LIMITED (HK) 2023-09-07 US disclosed
US-20210309622-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES VERSITECH LIMITED (HK) 2021-10-07 US disclosed
US-11052078-B2 Compounds affecting pigment production and methods for treatment of bacterial diseases VERSITECH LIMITED (CN) 2021-07-06 US disclosed
US-11040949-B2 Compounds affecting pigment production and methods for treatment of bacterial diseases VERSITECH LIMITED (CN) 2021-06-22 US disclosed
US-20200392095-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES THE UNIVERSITY OF HONG KONG (HK) 2020-12-17 US disclosed
US-20200261438-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES THE UNIVERSITY OF HONG KONG (HK) 2020-08-20 US disclosed
US-20190022038-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES VERSITECH LIMITED (HK) 2019-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11040949-B2 Compounds affecting pigment production and methods for treatment of bacterial diseases TYR, ALAD, NQO1 HDAC1 3174/4885MMP1 1317/4885MMP2 1543/4885
US-20200392095-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 HDAC1 3174/4885MMP1 1317/4885MMP2 1543/4885
US-11052078-B2 Compounds affecting pigment production and methods for treatment of bacterial diseases TYR, ALAD, NQO1 HDAC1 3174/4885MMP1 1317/4885MMP2 1543/4885
US-20210309622-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 HDAC1 3174/4885MMP1 1317/4885MMP2 1543/4885
US-20200261438-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 HDAC1 3174/4885MMP1 1317/4885MMP2 1543/4885
US-20230278971-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 HDAC1 3174/4885MMP1 1317/4885MMP2 1543/4885
US-20190022038-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 HDAC1 3174/4885MMP1 1317/4885MMP2 1543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.